General Information of Drug (ID: DML6FI3)

Drug Name
Naphthalene Trisulfonate Drug Info
Synonyms
naphthalene-1,3,6-trisulfonic acid; 86-66-8; 1,3,6-Naphthalenetrisulfonic acid; Naphthalene-1,3,6-trisulphonic acid; CHEBI:32916; 123409-01-8; EINECS 201-690-8; AC1Q6WKO; 6321-17-1; 19437-42-4; SCHEMBL305166; AC1L1I64; CHEMBL1160117; DTXSID9058945; CTK2F6984; ZPBSAMLXSQCSOX-UHFFFAOYSA-N; ZINC1664865; Naphtalene-1,3,6-trisulfonic acid; 3611AC; AKOS015964183; OR51840; AJ-28977; AX8143250; KB-258586; ST50826289; 1,3, -Naphthalenetrisulfonicacid, trisodium salt, hydrate (9CI)
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
4437
ChEBI ID
CHEBI:44434
CAS Number
CAS 19437-42-4
TTD Drug ID
DML6FI3

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CVBT-141H DMYPXQ2 Coronary artery disease BA80 Phase 2 [2]
Riferminogene pecaplasmid DMBKN4P Critical limb ischemia BD4Y Discontinued in Phase 3 [3]
Formic Acid DMNFZC6 Discovery agent N.A. Investigative [1]
N,O6-Disulfo-Glucosamine DMYCV7U Discovery agent N.A. Investigative [1]
O2-Sulfo-Glucuronic Acid DME78MS Discovery agent N.A. Investigative [1]
5-AMINO-NAPHTALENE-2-MONOSULFONATE DMYTUNE Discovery agent N.A. Investigative [4]
Sucrose Octasulfate DMET64R Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Heparin-binding growth factor 1 (FGF1) TTMY81X FGF1_HUMAN Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 Clinical pipeline report, company report or official report of CVBT.
3 Riferminogene pecaplasmide. Am J Cardiovasc Drugs. 2010;10(5):343-6.
4 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.